SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParkmead Regulatory News (PMG)

Share Price Information for Parkmead (PMG)

Share Price is delayed by 15 minutes
Get Live Data
18.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.50 (8.333%)
Market Cap: £20.49m
PMG Live PriceLast checked at - London Stock Exchange

Intraday Parkmead Share Chart

Update

21 Dec 2005 07:01

Interregnum PLC21 December 2005 RNS Announcement 21 December 2005 INTERREGNUM PLC Trading Update Interregnum plc, the technology merchant bank, provides a trading update for thesix months ending 31 December 2005. Interregnum's revenues for the period areover £6m, which represents a 90% increase over the same period last year. Theportfolio has increased in value and Interregnum has achieved operationalprofitability. Trading Update Interregnum's consolidated revenues for the six months ending 31 December 2005(H1 2005-6) will be over £6m (H1 2004-5: £3.3m). This reflects a significantincrease in the performance of all three of Interregnum's operating companies;Interregnum plc, Audio Visual Machines Ltd (AVM) and Yospace Ltd. Highlights from the key components of Interregnum's business are as follows: Quality and quantity of advisory deals increasing steadily: •Advised on the sale of a £40m portfolio to Coller Capital, which generated £700k in net success fees to Interregnum. •Client portfolio valuation exercise completed in a month which brought in £125k in fees to Interregnum. •Interregnum's US operations are growing steadily - DestiNY USA has contributed £500k of revenue in the period and the first two significant non-Destiny US client mandates have been signed. •Eight new corporate finance mandates secured in the period. Operational subsidiaries and investments performing well: •AVM is growing rapidly: November 05 results showed £776k in revenue, with £72k profit before tax. AVM is on track to achieve full year targets following the successful acquisition of Video Meeting Company in September 05. •As previewed in the Annual Results for 2004-5, Yospace revenues are growing steadily and it has reached operating profitability month-on-month. •The funding for Red-M Ltd was completed in December 05 with a successful private placing raising £4.6m. The business is well-funded to achieve its growth strategy. Interregnum now owns approximately 20% of the issued share capital of Red-M, in addition to some secured debt. •Respond Ltd is trading very profitably. It is generating cash and continuing the repayment of debt to Interregnum ahead of schedule. •In a new addition to the portfolio, Interregnum received shares in Retento Ltd valued at £180k (based on the last rights issue pricing), earned as part of its merchant banking relationship. Retento is the holding company for Prevx, a next-generation security software provider (www.prevx.com). Interregnum Chairman and CEO, Ken Olisa, commented: "I am delighted with thisperformance. The results of the first half prove that the technology merchantbanking model that Interregnum has pioneered is both profitable andvalue-creating." - Ends - Contacts: Interregnum 020 7494 3080Ken Olisa, Chairman and CEO Merlin (PR advisers to Interregnum) 020 7653 6620Rebecca Penney Notes to Editor Interregnum plc (www.interregnum.com) is a technology merchant bank listed onLondon's Alternative Investment Market (symbol: ITR). Established in 1992,Interregnum buys, sells, advises, invests in and operates technology companies.Its advisory services include corporate finance, IP exploitation and commercialdue diligence. The company's clients are principally corporates, government,technology entrepreneurs, advisors and investors. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th May 201010:00 amRNSFaroe Petroleum Rights Issue
10th Mar 20107:00 amRNSHalf Yearly Report
5th Feb 20107:00 amRNSChange of Registered Office
31st Dec 200912:24 pmRNSAGM Statement
24th Dec 200912:29 pmRNSNotification of Change in Directors Details
22nd Dec 200910:37 amRNSDirectorate Change
4th Dec 20097:00 amRNSPreliminary results
6th Nov 20098:01 amRNSHolding(s) in Company
4th Nov 20091:48 pmRNSTotal Voting Rights
2nd Nov 200911:52 amRNSResult of Meeting
12th Oct 20097:00 amRNSAcquisition
14th Sep 200910:57 amRNSHolding(s) in Company
22nd Jun 200912:10 pmRNSDirector/PDMR Shareholding
21st May 20093:53 pmRNSHolding(s) in Company
31st Mar 20097:00 amRNSInterim Results
3rd Dec 20084:20 pmRNSResult of AGM
21st Nov 200811:36 amRNSResult of EGM
10th Nov 20083:54 pmRNSAnnual Report and Accounts
6th Nov 20085:01 pmRNSReconvening of EGM
31st Oct 20081:53 pmRNSReconvening of EGM
27th Oct 200812:48 pmRNSResult of EGM
17th Oct 20087:53 amRNSFinal Results
3rd Oct 20083:21 pmRNSAdoption of new Articles of Association
15th Aug 20087:30 amRNSDirectorate Change
17th Jun 20087:00 amRNSStatement re Investment
16th Jun 200810:30 amRNSHolding(s) in Company
12th Jun 20087:05 amRNSHolding(s) in Company
12th Jun 20087:00 amRNSHolding(s) in Company
19th May 20087:00 amRNSCreation of Advisory Board an
11th Feb 200811:56 amRNSHolding(s) in Company
8th Feb 20087:00 amRNSInterim Results
21st Dec 20073:55 pmRNSResult of AGM
12th Dec 20074:21 pmRNSAcquisition-Amendment
6th Dec 20074:59 pmRNSAcquisition
30th Nov 20077:10 amRNSInvestment
30th Nov 20077:01 amRNSAudited Final Results
8th Nov 20073:57 pmRNSDisposal
27th Sep 20072:02 pmRNSFinal Results
15th Aug 20076:20 pmRNSAIM Rule 26 Information
10th Aug 20077:00 amRNSChange of Adviser
13th Jul 20074:02 pmRNSHolding(s) in Company
29th Jun 20078:00 amRNSDirectorate Change
4th Jun 200712:32 pmRNSHolding(s) in Company
21st Mar 20077:02 amRNSInterim Results
20th Feb 20077:00 amRNSDisposal
2nd Feb 20078:14 amRNSDisposal
15th Dec 20061:08 pmRNSTotal Voting Rights
11th Dec 20064:36 pmRNSAdditional Listing
19th Oct 20067:01 amRNSPreliminary Results
6th Oct 20061:32 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.